PROCARE-prevention in stationary care facilities- prevention program for caregivers
Phase 2
- Conditions
- M00-M99Diseases of the musculoskeletal system and connective tissue
- Registration Number
- DRKS00015249
- Lead Sponsor
- niversität Hamburg, Arbeitsbereich Gesundheitswissenschaft
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
The study includes employees who are active in the care of residents and who have no acute and/or chronic diseases of the back.
Exclusion Criteria
Excluded are professional housekeepers, psycho-social carers and administrative staff.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcomes include the following parameters: Parameter: Lifting capacity, method of measurement: PILE Test, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Predisposition of the upper body, method of measurement: Xsens, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Strength endurance of lumbar extensors, method of measurement: Biering-Sorensen Test, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks.
- Secondary Outcome Measures
Name Time Method The secondary outcomes include the following parameters: Parameter:Total score of movement observation (wheelchair transfer), method of measurement: Movement observation sheet, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Functional impairment due to back pain, questionnaire: Oswestry Disability Index, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Pain intensity of back complaints, scale: VAS, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks.